MedPath
FDA Approval

ZALEPLON

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 31, 2011
Labeling Type
Human Prescription Drug Label
Zaleplon(10 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Ascend Laboratories, LLC

141250469

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Unichem Laboratories Limited

H.J. Harkins Company, Inc.

Ascend Laboratories, LLC

915389741

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ZALEPLON

Product Details

NDC Product Code
52959-957
Application Number
ANDA078989
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 31, 2011
ZaleplonActive
Code: S62U433RMHClass: ACTIBQuantity: 10 mg in 1 1
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
SILICON DIOXIDE, COLLOIDALInactive
Code: ETJ7Z6XBU4Class: IACT
LACTOSEInactive
Code: J2B2A4N98GClass: IACT
GELATINInactive
Code: 2G86QN327LClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
FERRIC OXIDE BLACKInactive
Code: XM0M87F357Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBDClass: IACT
© Copyright 2025. All Rights Reserved by MedPath
ZALEPLON - FDA Approval | MedPath